Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cell-based platforms for antiviral screening against hepatitis B virus: advantages, limitations, and future perspectives.

Antiviral research·2026
Same author

Hepatitis B virus covalently closed circular DNA formation in murine hepatic cells uncovers a late entry block.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Factor VIII originates primarily from anatomically distinct subsets of liver sinusoidal endothelial cells.

Blood advances·2026
Same author

Profuse nocturnal eyelid haemorrhage from a spider angioma.

Acta ophthalmologica·2026
Same author

Halting Hypercaloric Feeding in Liver Chimeric Mice Rapidly Resolves Human Hepatocyte Steatosis.

Gastro hep advances·2025
Same author

Gene-based therapies for steatotic liver disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same journal

Hepatosystemic T cell licensing in MASLD-associated neuroinflammation.

Seminars in liver disease·2026
Same journal

Endothelial Cell Therapy for the Acute and Chronic Liver Disease.

Seminars in liver disease·2026
Same journal

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Seminars in liver disease·2026
Same journal

Expert Practical Recommendations for Hepatocellular Carcinoma.

Seminars in liver disease·2026
Same journal

Optimizing Liver Cancer Care Through BCLC Principles.

Seminars in liver disease·2026
Same journal

Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.

Seminars in liver disease·2026
See all related articles

Related Experiment Video

Updated: Jun 13, 2025

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
11:44

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells

Published on: August 29, 2016

10.9K

Mice Engrafted with Human Liver Cells.

Ype P de Jong1,2

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, New York, New York.

Seminars in Liver Disease
|September 12, 2024
PubMed
Summary
This summary is machine-generated.

Human hepatocyte transplantation into mice creates advanced preclinical models for liver disease research, overcoming rodent species limitations. These chimeric mouse models are crucial for studying various liver conditions and developing new therapies.

More Related Videos

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
00:10

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

8.6K
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

36.0K

Related Experiment Videos

Last Updated: Jun 13, 2025

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells
11:44

Generation of a Humanized Mouse Liver Using Human Hepatic Stem Cells

Published on: August 29, 2016

10.9K
Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
00:10

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

8.6K
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

36.0K

Area of Science:

  • * Biomedical research
  • * Preclinical disease modeling
  • * Translational medicine

Background:

  • * Rodent models have limitations in accurately mimicking human liver conditions due to species differences.
  • * Human hepatocyte transplantation into rodents aims to overcome these translational barriers.
  • * Early successes involved supporting viral hepatitis infections (hepatitis B and C) in mice.

Purpose of the Study:

  • * To review the evolution and applications of hepatocyte chimeric mouse models.
  • * To highlight advancements in humanizing mouse models beyond hepatocytes.
  • * To identify ongoing challenges and future directions in the field.

Main Methods:

  • * Transplantation of primary human hepatocytes into immunodeficient mice with induced liver injury.
  • * Development of methods for cotransplanting other human cell types.
  • * Strategies for humanizing immune and nonparenchymal liver compartments.

Main Results:

  • * Hepatocyte chimeric mice are now widely used in preclinical research for diverse liver conditions.
  • * Applications include modeling viral hepatitis, malaria, drug metabolism, gene therapy, and metabolic liver diseases.
  • * Successful humanization of immune and nonparenchymal cells alongside hepatocytes has been achieved.

Conclusions:

  • * Hepatocyte chimeric mice represent a significant advancement over traditional rodent models for liver disease research.
  • * These models address key limitations of rodent species differences.
  • * Future improvements focus on enhancing immune functionality, genetic modification of grafts, and using patient-specific stem cells for more robust humanization.